Title
Category
Credits
Event date
Cost
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are the steps for diagnosing Alzheimer disease? Are you familiar with diagnostic criteria and assessment tools? In this webcast, walk through the process with an expert.
  • Alzheimer Disease
  • Dementia
  • Neurology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. Here, learn strategies for disclosing the diagnosis.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Evaluating cognition in older adults when possible cognitive impairment and dementia are present can be quite beneficial. Learn more in this CME activity.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Primary Care
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Learn from experts in neurology, psychiatry, neuropsychology, and primary care about working with patients and care partners to create management plans for Alzheimer’s disease that ensure safety, optimize patient autonomy, and minimize agitation and conflict.
  • Alzheimer Disease
  • Cognition
  • Delivery of Care
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Patient/Physician Communication
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer’s disease.
  • Alzheimer Disease
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
  • Violence/Aggression
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
When you treat patients with dementia-related psychosis, do you evaluate the burden on carers, too? If they feel discomfort, fear, or depression, how would you help them? Learn from an expert in this brief CME activity.
  • Alzheimer Disease
  • Dementia
  • Neurology
  • Sleep
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
OverviewFor people living with Alzheimer disease, sleep disturbances are often problematic for the patient and their family. In this CME webcast, watch short videos to gain insight from experts into the recognition and treatment of insomnia in these patients.
  • Alzheimer Disease
  • Anxiety
  • Depression
  • Diagnostic Tools
  • Neuroimaging
  • Neurology
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
How do you proceed when a patient younger than 65 presents with cognitive complaints? Early-onset Alzheimer’s disease may not appear in the typical presentation that you expect from AD. Follow along with this case from experts at Banner Alzheimer’s Institute.
  • Alzheimer Disease
  • Dementia
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Great strides in research on Alzheimer disease diagnostic biomarkers and treatment targets have taken place over the past 2 decades. Listen as Dr Goldfarb highlights exciting developments.

Pages